An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass
Clinical trial NCT00078026 · TERMINATED
Trial details
- NCT number
- NCT00078026
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.